NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 240 filers reported holding NEKTAR THERAPEUTICS in Q3 2021. The put-call ratio across all filers is 0.30 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,697 | +3.5% | 2,850 | 0.0% | 0.00% | – |
Q2 2023 | $1,639 | -18.2% | 2,850 | 0.0% | 0.00% | – |
Q1 2023 | $2,003 | -68.9% | 2,850 | 0.0% | 0.00% | – |
Q4 2022 | $6,441 | -28.4% | 2,850 | 0.0% | 0.00% | – |
Q3 2022 | $9,000 | -18.2% | 2,850 | 0.0% | 0.00% | – |
Q2 2022 | $11,000 | -26.7% | 2,850 | 0.0% | 0.00% | – |
Q1 2022 | $15,000 | -61.5% | 2,850 | 0.0% | 0.00% | – |
Q4 2021 | $39,000 | -23.5% | 2,850 | 0.0% | 0.00% | – |
Q3 2021 | $51,000 | +4.1% | 2,850 | 0.0% | 0.00% | – |
Q2 2021 | $49,000 | -14.0% | 2,850 | 0.0% | 0.00% | – |
Q1 2021 | $57,000 | +18.8% | 2,850 | 0.0% | 0.00% | – |
Q4 2020 | $48,000 | +2.1% | 2,850 | 0.0% | 0.00% | – |
Q3 2020 | $47,000 | -28.8% | 2,850 | 0.0% | 0.00% | – |
Q2 2020 | $66,000 | +29.4% | 2,850 | 0.0% | 0.00% | – |
Q1 2020 | $51,000 | -17.7% | 2,850 | 0.0% | 0.00% | – |
Q4 2019 | $62,000 | +17.0% | 2,850 | -1.2% | 0.00% | – |
Q3 2019 | $53,000 | -47.5% | 2,885 | +1.2% | 0.00% | -100.0% |
Q2 2019 | $101,000 | – | 2,850 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Cormorant Asset Management, LP | 1,828,400 | $89,281,000 | 6.61% |
Cormorant Asset Management, LP | 1,500,000 | $73,245,000 | 5.42% |
Camber Capital Management LP | 2,000,000 | $97,660,000 | 3.76% |
Rhenman & Partners Asset Management AB | 617,652 | $30,160,000 | 3.09% |
BRIDGER MANAGEMENT, LLC | 1,134,414 | $55,393,000 | 3.00% |
First Light Asset Management, LLC | 374,251 | $18,275,000 | 2.84% |
Gs Investments, Inc. | 54,000 | $2,636,820,000 | 1.97% |
SABBY MANAGEMENT, LLC | 241,922 | $11,813,000 | 1.82% |
QUANTRES ASSET MANAGEMENT Ltd | 50,000 | $2,441,000 | 1.41% |
Tibra Equities Europe Ltd | 173,183 | $8,457,000 | 1.27% |